ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Vitamin D supplementation could ease IBS symptoms

Increase Your Magnesium Intake

Top Tips to Boost Your Immunity

11 Amazing Health Benefits of Using Baking Soda

Nicotinamide riboside shows promise for treatment of Alzheimer’s disease

Exercise, calcium, vitamin D, and other factors linked with fewer injurious falls

Vitamin D3 Is a Powerhouse for Your Heart

Rhodiola — A Powerful Adaptogen That Boosts Vitality and Performance, Eases Depression and Combats B...

Curcumin Supplementation May Impart Long-Term Cognitive Benefits

Vitamin D deficiency during pregnancy can program obesity in children

 
Print Page
Email Article

Protein fragment found to help improve chemotherapy

  [ 125 votes ]   [ Discuss This Article ]
www.ProHealth.com • May 20, 2003


USC researchers find ways to improve effectiveness against tumors
Los Angeles, Calif., May 20--Researchers from the Keck School of Medicine of the University of Southern California have isolated a protein fragment derived from the cancer immunotherapy drug interleukin 2 (IL-2) that seems to enhance the uptake of chemotherapeutic agents into tumors.

In fact, says Alan Epstein, M.D., Ph.D., professor of pathology at the Keck School of Medicine, when this patented protein fragment is attached to a tumor-targeting antibody, it can prompt tumors to soak up more than 300 percent the normal amount of chemotherapy drugs. It does this, Epstein says, by making the tumor's blood vessel walls more "open" or permeable to the drugs. (Blood vessel walls are made of epithelial cells that are usually tightly joined together; when the junctions between those cells loosen up, it becomes easier for molecules to enter or leave the bloodstream.)

This work was described in a paper being published in the May 21, 2003 issue of the Journal of the National Cancer Institute.

The interleukins are part of a class of proteins called cytokines, which play a role in the human immune response. It's been hoped that interleukin 2 (IL-2) and its brethren might play a central role in cancer immunotherapy-battling cancer by revving up the immune system. Unfortunately, IL-2 can only be tolerated in small doses by the body. Taken at levels that would take advantage of its therapeutic value, it causes wide-spread edema and other problems due to blood vessel leakiness.

While seeking the cause of this leakiness, Epstein and his Keck School of Medicine colleagues isolated a stretch of 37 amino acids on the IL-2 protein; this sequence, he says, "is responsible for 100 percent of the vasopermeability." Dubbed PEP, for permeability-enhancing peptide, the molecule is now being commercially developed by Peregrine Pharmaceuticals of Tustin, Calif.

Having determined that PEP is indeed a permeability enhancer, Epstein and his colleagues took their exploration a step further: They transplanted mice with human tumor cells and pretreated them with monoclonal antibodies coupled with PEP.

When these mice and control mice were later injected with a radiolabeled tracer antibody or drug, there was a three to four fold increase in the amount of the antibody taken up by the tumors of the pretreated mice than those of the control mice.

"We've showed that you can use PEP to induce selective and reversible blood vessel permeability at the tumor site to get better drug uptake," says Epstein. "This may turn out to be a hugely important tool in cancer therapy."

The next step, he says, "is to try to get this product ready to test in human patients."



This work was supported by grants from the National Cancer Institute, Peregrine Pharmaceuticals, Inc. and Cancer Therapeutics Laboratories.

Alan L. Epstein, Myra Mizokami, Jiali Li, Peisheng Hu, Leslie A. Khawli, "Identification of a Protein Fragment of Interleukin 2 Responsible for Vasopermeability." Journal of the National Cancer Institute, Vol. 95, No. 10, May 21, 2003, pp. 741-749.



Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil Energy NADH™ 12.5mg Vitamin D3 Extreme™


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get Energized with Malic Acid & Magnesium
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

Block Acid Reflux to Prevent Esophageal Problems! Block Acid Reflux to Prevent Esophageal Problems!
Looking for Energy? Turn to Plants. Looking for Energy? Turn to Plants.
Top 3 Nutrients to Detox the Liver and Soothe Digestion Top 3 Nutrients to Detox the Liver and Soothe Digestion
The Brain Boosting and Fatigue Fighting B-12 The Brain Boosting and Fatigue Fighting B-12
Astaxanthin - A Little-Known but Power-Packed Nutrient Astaxanthin - A Little-Known but Power-Packed Nutrient

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2018 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map